The maker of instruments used in biomedical research posted revenue of $571.6 million in the period. Bio-Rad shares have risen 21% since the ...
News
- Bio-Rad: 1Q Earnings Snapshot
- Enanta Pharmaceuticals: Fiscal 2Q Earnings Snapshot
The biotechnology company posted revenue of $27.6 million in the period, which did not meet Street forecasts. Four analysts surveyed by Zacks ...
- A mysterious illness is striking children amid the coronavirus pandemic – but don't be too quick to ...
I also do biomedical research using the body's immune responses, particularly the antibodies produced, to help find the cause of illness and to help ...
- Robot Zaps Germs And Disinfects In Minutes, Firm Hopeful It Can Help Combat Coronavirus
... which was developed by Xenex, a company based in San Antonio, Texas, ... The independent Texas Biomedical Research Institute confirmed that ...
- Quest for a coronavirus treatment involves door-to-door blood collection and a llama named Winter
Vir Biotechnology, which also plans to start human tests this summer, hired a ... The company that did the blood draws, Sanguine Biosciences, sent ...